Showing 381-390 of 7162 results for "".
DWTV Extra: Image-Guided SRT Consensus
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-image-guided-srt-consensus/35744/Jacob Scott, MD, chairman of the Dermatology Association of Radiation Therapy (DART), discusses an expert panel's recommendations on the role of image-guided superficial radiation therapy in the treatment of non melanoma skin cancer, which were published in an article titled "The Role of Image-GuideBreaking a Sweat: Treating Hyperhidrosis in the COVID-19 Era
https://practicaldermatology.com/series/dermatology-dispatches/breaking-a-sweat-treating-hyperhidrosis-in-the-covid-19-era/19767/Hyperhidrosis patients can be evaluated with telemedicine, says Neal Bhatia, MD. It’s important that these individuals have adequate supplies of their medication for the duration of any stay-at-home orders. In addition, dermatologists should try to distinguish between anxiety-induced sweating and prExosomes 101
https://practicaldermatology.com/conferences/scale-2023/exosomes-101/20192/Exosomes are today's hottest skincare ingredient, and Glynis Ablon, MD, gives viewers the scoop on how and when to use them.Skin Cancer Perceptions, Cimzia for Psoriasis, Eczema and CV Risk
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-skin-cancer-perceptions-cimzia-for-psoriasis-eczema-and-cv-risk/18301/A new national survey, Skin Cancer In America 2018, conducted by Health Union, explores perceptions of patients with skin cancer. Cimzia (certolizumab pegol, UCB) has received FDA approval for treatment of adults with moderate to severe plaque psoriasis. Cimzia is the first Fc-free, PEGylated anti TDWTV Extra: Rocatinlimab Trials
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-rocatinlimab-trials/39044/Clinical investigator Emma Guttman-Yassky, MD, PhD, discusses two sets of data presented at the European Academy of Dermatology and Venereology (EADV) Congress 2025. The phase 3 ROCKET-Ignite Trial evaluated the efficacy and safety of OX40-receptor targeting with rocatinlimab in moderate-to-severe aEvaluating GEP Test Options
https://practicaldermatology.com/programs/practical-dermatology/evaluating-gep-test-options/35600/David Cotter, MD, a board-certified dermatologist, discusses what he looks for in a gene expression profile (GEP) test, including the types of clinical evidence that are most important.Energy-based Devices for Fat Reduction
https://practicaldermatology.com/conferences/maui-derm-2024/energy-based-devices-for-fat-reduction/20236/Michael H. Gold, MD, founder and medical director of the Gold Skin Care Center in Nashville, highlights new energy-based devices for fat reduction, including those utilizing lasers and radio frequency technology for muscle stimulation.DermWireTV: Novan EPI Acquisition, Champions for Change Gala, Mt. Sinai Alopecia Center
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-novan-epi-acquisition-champions-for-change-gala-mt-sinai-alopecia-center/20070/EPI Health is now a Novan company; the combined company will employ approximately 100 staff. Novan’s lead candidate, berdazimer gel 10.3%, performed well in a phase 3 study for the treatment of molluscum contagiosum. The Skin Cancer Foundation is gearing up for its signature fundraising event: The CThe Easy Es of Managing Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/the-easy-es-of-managing-eczema/19978/Atopic dermatitis can have a profound effect on patients' lives—from associated comorbidities to sleep issues and more. Adam Friedman, MD says it’s essential to Educate patients regarding good skin care, manage Expectations, provide Enough appropriate medication, End misdiagnoses, and Engage assistaDERM2020 Attendee Reaction: Emmanual Agnant, PA-C
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-attendee-reaction-emmanual-agnant-pa-c/19838/Emmanual Agnant, PA-C from Bronx, NY shares his thoughts on participating in DERM2020.